NIH-funded research Fellowship grant

Investigating how gut bacteria affect pain sensitivity after early morphine exposure

Official title: Role of the gut microbiome in prolonged pain hypersensitivity following neonatal morphine exposure

Funded at University of Miami School of Medicine · NIH-10900887 · Data updated 2026-11-12

This study is looking at how being exposed to morphine as a newborn might change how sensitive someone is to pain later in life, especially by looking at the role of gut bacteria, and it aims to find new ways to help manage pain for those who experienced this early exposure.

More Gut Microbiome research and trials

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Miami School of Medicine
NIH-funded
Lab location1 site (Coral Gables, United States)
Project startJuly 1, 2024
Project endJune 30, 2025
Funding year2024
Award (this year)$48,974
NIH project number1F31DA059204-01A1
Project IDNIH-10900887 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals who have experienced neonatal morphine exposure and are currently dealing with prolonged pain sensitivity.

Less likely to help

Patients who have not been exposed to morphine during neonatal development may not benefit from this research.

What this research studies

This research explores how exposure to morphine during neonatal development can lead to long-lasting changes in pain sensitivity, particularly focusing on the gut microbiome's role. Using a murine model, the study examines how alterations in gut bacteria may contribute to persistent pain hypersensitivity through mechanisms involving neuroinflammation. The researchers will employ techniques like Fecal Microbial Transplantation to understand the causal relationship between gut microbiome changes and pain sensitivity. This investigation aims to uncover potential therapeutic targets for managing pain in individuals with a history of neonatal morphine exposure.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for managing chronic pain in individuals affected by early morphine exposure.

How similar studies have gone: While the specific focus on gut microbiome alterations due to neonatal morphine exposure is novel, related research has shown promising results in understanding the gut-brain axis and its impact on pain.

Where this research is happening

  • University of Miami School of Medicine
    Coral Gables, United States
    Active

Researchers

  • Principal investigator: Antoine, Danielle — University of Miami School of Medicine
  • Study coordinator: Antoine, Danielle

Related research

Other NIH-funded projects on the same topics.

  • Multi-agent AI to annotate enzymes in the human gut microbiome

    A team at a major university will build an AI system that automatically curates and labels the functions of enzymes in the human gut microbiome to speed up understanding their health effects.

    NIH research University of South Florida · Tampa, United States · NIH-11594384

  • Mapping how gut bacteria transform drugs

    Scientists will study how the gut microbiome changes thousands of drugs into new forms, which could affect how well a medicine works or whether it causes side effects.

    NIH research Stanford University · Stanford, United States · NIH-11550022

  • Aflatoxin exposure and child growth in Guatemala

    A study in rural Guatemala will track how exposure to aflatoxin relates to growth and gut health in young children.

    NIH research Arizona State University-Tempe Campus · Scottsdale, United States · NIH-11513260

  • Gut bacteria that can make cancer immunotherapy less effective

    This project will see if reducing chronic inflammation driven by certain gut bacteria can help immunotherapy work better for people whose cancers have stopped responding.

    NIH research University of Tx Md Anderson Can Ctr · Houston, United States · NIH-11478145

  • How gut bacteria affect how cancer drugs work

    This project looks at how the bacteria in your gut might change how well and with what side effects fluoropyrimidine cancer drugs like 5-FU work in people.

    NIH research University of California, San Francisco · San Francisco, United States · NIH-11473234

  • Gut bacteria and cancer drugs: how your gut may change chemotherapy effectiveness

    This project studies how the gut microbiome might affect how well certain chemotherapy drugs work and their side effects in people with cancer.

    NIH research University of California, San Francisco · San Francisco, United States · NIH-11473233

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.